Melanoma antigen preferentially expressed in tumors (100-108)

Ask supplier a question | View on supplier's website

Melanoma antigen preferentially expressed in tumors (100-108) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor.

Supplier	BOC Sciences
Product #	BAT-009680
Pricing	Inquire

Feedback